Which GLP-1 Program Is Right for You? Compare Options

It is late, the house is quiet, and you have gotten as far as the pricing page. You have already made peace with the idea that a GLP-1 might be the medical option you have been circling for months. If you have put in years of real effort and watched it stop paying off, that is not a discipline problem. Bodies change, and biology can work against effort that has not slipped at all. Now there are three programs in front of you at three different prices, and there is no obvious way to tell which one is yours. That is a fair place to be stuck.

Here is the part that should take some pressure off: this is an information gap, not a decision you have to make alone or get exactly right on the first try. You do not have to pick your own medication, guess at your own dose, or worry that choosing the lower-priced option means you are shortchanging yourself. A licensed provider makes the final determination about which medication, if any, is appropriate for you, based on your health history.

Your job on this page is smaller and calmer: understand how the three programs actually differ, see what a provider weighs when they decide, and then complete the free assessment. No page and no person can tell you in advance exactly what you will be prescribed, and that is genuinely good news. It means the answer is tailored to your body, not to a checkout button.

The three programs at a glance

Transformation Health offers three GLP-1 programs. All three are all-inclusive: your monthly fee covers the medication, lab work (through Quest or Labcorp), provider care, and coaching, with no hidden fees, and you can cancel anytime. Here are the current, config-driven prices for each.

Price is only one dimension, and honestly the least useful one for figuring out which program fits. The more important differences are what the medication does, how you take it, and the dose level. Here is each program described by those factors.

How the programs actually differ

Strip away the pricing and there are really three distinctions that matter: mechanism, form, and dose level.

Mechanism. Semaglutide is a GLP-1 receptor agonist, meaning it acts on a single receptor pathway. Tirzepatide, and the tirzepatide-based Microdose formulation, act on two: both the GLP-1 and the GIP receptors. In plain terms, these receptors are involved in appetite signaling and in how quickly your stomach empties, which is why people often describe a quieter relationship with food on these medications. If that food noise got louder for you in your late thirties or forties, that lines up with perimenopause, when estrogen decline shifts fat storage toward the midsection and changes how appetite signals work. That is biology, not a lapse in effort. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes this class of medications as working on appetite and fullness signals ^[1]. A dual-mechanism medication is not automatically “better” than a single-mechanism one. The two molecules have each been studied separately in large clinical trials (semaglutide in the STEP program ^[2] and tirzepatide in the SURMOUNT program ^[3]), and which one suits a given person is an individual clinical judgment.

Form. Semaglutide can be taken as a weekly injection or as a daily oral tablet, and it is the only oral option offered. The Microdose program and the tirzepatide program are injectable only, given as a weekly injection. The tradeoff is straightforward and personal: a once-weekly injection is less frequent but involves a small needle, while a daily tablet means no needle but a daily routine to keep. Neither is the “right” answer in the abstract. It depends on what you will actually stick with.

Dose level. The Microdose program is a lower-dose approach, which is why it is often relevant to people maintaining results after prior GLP-1 use, or to lower-BMI situations. The standard semaglutide and tirzepatide programs use standard dosing. Dose is a clinical decision, not a menu item.

Cost. All three programs are all-inclusive, covering medication, lab work, provider care, and coaching, with no hidden fees and cancel-anytime terms. Refer back to the pricing above for current figures. No plan is a “lesser” plan. They fit different situations.

What your provider actually weighs

This is where the decision anxiety should ease. You are not the one who has to land the final call, and you are not locked into whatever you click. An independent, licensed provider reviews your complete health history and determines which medication, if any, is appropriate. Here is what goes into that review.

BMI is where a lot of the “am I even a candidate” worry lives, so here are the actual numbers. According to NIDDK, the general thresholds are a BMI of 27 or higher with a weight-related condition (such as high blood pressure or prediabetes), or a BMI of 30 or higher on its own ^[1]. BMI alone does not determine anything, though. You may be a candidate, and a licensed provider makes the final determination based on your full health picture. For the specifics, see our GLP-1 eligibility requirements.

One process detail belongs here. Residents of Arkansas, DC, Delaware, Mississippi, New Mexico, Rhode Island, and West Virginia are required by state law to complete a one-time live video consultation before a prescription can be written.

Could the Microdose program be a fit?

The Microdose program is the most misread of the three, usually because it carries the lowest price. So here it is accurately. It is a lower-dose, injectable-only, tirzepatide-based (GLP-1/GIP) program. It tends to fit two situations: people who have prior GLP-1 experience and want to maintain results at a lower dose, and lower-BMI first-timers (BMI 20 or higher) who are starting at a lower-dose protocol. It is not a discount version of the standard program, and it is not a shortcut around eligibility.

If that description sounds like where you are, it is worth reading the microdosing approach and our detailed pillar on lower-dose tirzepatide to understand how these protocols work. As with every program here, a licensed provider confirms whether it is appropriate for you. Want a closer look at the two molecules side by side first? See semaglutide vs. tirzepatide, compared.

How Transformation Health approaches program selection

The process is built so that the medical decision sits with a provider, not with a shopping cart. It works like this.

You complete a free online assessment, which takes about 5 minutes and covers your health history, current medications, goals, and any form preference. An independent, licensed provider reviews that information and determines whether a GLP-1 medication is appropriate and, if so, which program and dose fit your situation. If a prescription is written, your medication is prepared by a state-licensed compounding pharmacy and shipped to your door. Medication ships via 2-day priority mail and typically arrives in 3 to 5 business days.

You are not buying a medication from Transformation Health and hoping it is the right one. You are being connected with an independent provider who makes that determination for you. If you want to see the full walkthrough, here is how the process works, and here is the broader picture of how to get a GLP-1 prescription online.

Information About Compounded Medications

Transformation Health works exclusively with U.S.-based, state-licensed compounding pharmacies. The medications in all three programs are compounded, and compounded medications are not FDA-approved.

According to the FDA ^[4]:

“This is a compounded medication. It is not FDA-approved. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality. Compounded drugs are not the same as FDA-approved generic drugs.”

The active ingredients, semaglutide and tirzepatide, are also used in certain medications the FDA has approved, but this compounded version has not been approved by the FDA and may differ in formulation, purity, and potency, and has not been independently evaluated by the FDA for safety, efficacy, or quality. Your provider will discuss the benefits and limitations of compounded medications with you.

All prescriptions require evaluation by a licensed healthcare provider. Not all patients will qualify. Medical provider will determine appropriateness of treatment. Individual results vary and depend on factors including diet, exercise, and medical supervision.

Citations

[1] National Institutes of Health (NIDDK). “Prescription Medications to Treat Overweight & Obesity.” https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

[2] Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” (STEP 1 trial) N Engl J Med. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/

[3] Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” (SURMOUNT-1 trial) N Engl J Med. 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/

[4] FDA. “Compounding and the FDA: Questions and Answers.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers